SMS PHARMACEUTICALS LTD. - 532815 - Notice Of Annual General Meeting To Be Held On 30-Sep-2022
Notice of Annual General Meeting to be held on 30-Sep-202207-09-2022
SMS PHARMACEUTICALS LTD. - 532815 - Notice Of Annual General Meeting To Be Held On 30-Sep-2022
Notice of Annual General Meeting to be held on 30-Sep-2022SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of Newspaper Publication regarding the 34th Annual General Meeting to be held through Video Conference/ Other Audio Visual MeansSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of copies of Newspaper Publication for information regarding transfer of shares to Investor Education Protection Fund (IEPF).SMS PHARMACEUTICALS LTD. - 532815 - Communication To Shareholders On Tax Deduction At Source ('TDS') On Dividend Payout.
Communication to shareholders on Tax Deduction at Source ('TDS') on dividend payout.SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Conference Call held on 18th August, 2022SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the first quarter ended 30th June, 2022.SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Financial ResultsSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation of the Company for the first Quarter ended 30th June, 2022.SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation of the Company for the first Quarter ended 30th June, 2022.